HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DE FRANCESCO DAHER, E. Articles by GUTIÉRREZ-ADRIANZÉN, O. A. Search for Related Content PubMed PubMed Citation Articles by DE FRANCESCO DAHER, E. Articles by GUTIÉRREZ-ADRIANZÉN, O. A.

RISK FACTORS FOR DEATH IN ACQUIRED IMMUNODEFICIENCY SYNDROME–ASSOCIATED DISSEMINATED HISTOPLASMOSIS

We performed a retrospective study of 164 human immunodeficiency virus (HIV)–infected patients with disseminated histoplasmosis to identify the risk factors for death. Death occurred in 32% of the cases. Univariate analysis identified the following risk factors: diarrhea (odds ratio [OR] = 3.9, P = 0.001), neurologic manifestations (OR = 5.8, ; P = 0.001), hemoglobin level < 8.0g/dL (OR = 2.7, P = 0.004), urea level 2 times the normal upper limit (OR = 5.0, P < 0.001), creatinine level > 1.5 mg/dL (OR = 2.9, P = 0.005), aspartate aminotransferase (AST) level > 2.5 times the normal upper limit (OR = 3.1, P = 0.01), respiratory insufficiency (OR = 9.7, P < 0.001), sepsis (OR = 20.2, P < 0.001), and acute renal failure (OR = 2.5, P = 0.011). A hemoglobin level < 8.0 g/dL (OR = 3.8, P = 0.008), an AST level 2.5 times the normal limit (OR = 1.0, P = 0.007), acute renal failure (OR = 2.96, P = 0.015), and respiratory insufficiency (OR = 12.2, P = 0.01) were independent risk factors for death.

Received September 21, 2005. Accepted for publication October 15, 2005.

Acknowledgments: We are very grateful to the physicians, residents, medical students, and nurses from the Hospital São José de Doenças Infecciosas for assistance provided to the patients and technical support.

Financial support: This research was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq, Brazil. Geraldo Bezerra da Silva Júnior and Marúsia Thomaz Ferreira were supported by a grant from CNPq.

^* Address correspondence to Geraldo Bezerra da Silva Ju' nior, Rua 25 de Marco, 997, Fortaleza, CE, Brazil CEP 60060-120. E-mail: geraldobezerrajr{at}yahoo.com.br or efdaher{at}for.terra.com.br

Authors’ addresses: Elizabeth de Francesco Daher, Fernando Antonio de Sousa Barros, Geraldo Bezerra da Silva Júnior, Marúsia Thomaz Ferreira, Julieta Cunha Martins, Soraya Alves Jacinto Oliveira, and Oswaldo Augusto Gutiérrez-Adrianzén, Department of Internal Medicine, Faculdade de Medicina, Hospital Universitário Walter Cantídio, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil, E-mails: efdaher{at}for.terra.com.br and geraldobezerrajr{at}yahoo.com.br. Christianne Fernandes Valente Takeda, Hospital São José de Doenças Infecciosas. Fortaleza, Ceará, Brazil. Rosa Maria Salani Mota, Department of Statistics, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.

This article has been cited by other articles:

				M. D. Lindsley, H. L. Holland, S. L. Bragg, S. F. Hurst, K. A. Wannemuehler, and C. J. Morrison Production and Evaluation of Reagents for Detection of Histoplasma capsulatum Antigenuria by Enzyme Immunoassay Clin. Vaccine Immunol., June 1, 2007; 14(6): 700 - 709. [Abstract] [Full Text] [PDF]